Adoptive therapy with chimeric antigen receptor (CAR)-redirected T cells showed spectacular efficacy in the treatment of leukaemia in recent early phase trials. Patient's T cells were ex vivo genetically engineered with a CAR. amplified and re-administered to the patient. While T cells mediating the primary response were predominantly of young effector and central memory phenotype. https://bellfordtoysandhobbiers.shop/product-category/book/